There was an oral presentation at ASCO 2009: Inhibition of ALK mutated neuroblastomas by the selective inhibitor PF-02341066. Abs.: <a href="http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=65&abstractID=35242" rel="nofollow" target="_blank">http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=65&abstractID=35242</a>